BiotechTube
Home/Diakonos Oncology/Will Decker, PhD
WD

Will Decker, PhD

CSO

Diakonos Oncology

Therapeutic Areas

Oncology

Diakonos Oncology Pipeline

DrugIndicationPhase
DOC1021Glioblastoma (GBM)Phase 2

Leadership Team at Diakonos Oncology

MW
Mike Wicks, MS
CEO and Board Member
DF
Dan Faust
Chairman
JH
Jay Hartenbach
President, COO
LA
Laura Aguilar, MD PhD
CMO
DR
Donna Rill
CTO
View full Diakonos Oncology profile